← FDA Drug Approvals (Drugs@FDA)
DOCOSANOL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2022-05-03
Drug application
- FDA Application #
ANDA215839- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOCOSANOL
- Generic name
- DOCOSANOL
- Active ingredients
- DOCOSANOL
- Dosage form
- CREAM
- Route
- TOPICAL
- Marketing status
- Over-the-counter
- Sponsor
- ALEMBIC
- Manufacturer
- Alembic Pharmaceuticals Limited
- First approval
- 2022-05-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown